MedTrace Logo

A Non-interventional Study to Identify Children and Adolescents With ADHD and With or Without mGLuR Mutations

NCT03233867 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2503

Last updated 2021-07-06

No results posted yet for this study

Summary

This is a non-interventional study in children and adolescents (ages 6-17 years) with attention deficit hyperactivity disorder (ADHD) to assess CNVs in specific genes involved in glutamatergic signaling and neuronal connectivity. The screening in this study will be conducted through a combination of online and site performed activities.

Conditions

  • Attention Deficit Hyperactivity Disorder

Sponsors & Collaborators

  • Aevi Genomic Medicine, LLC, a Cerecor company

    lead INDUSTRY

Principal Investigators

  • Andrew Cutler, MD · Meridien Research

Eligibility

Min Age
6 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-14
Primary Completion
2018-08-03
Completion
2018-08-03

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03233867 on ClinicalTrials.gov